Shandong Keyuan Pharmaceutical Co. Ltd. A Capital Reinvestment Ratio
Shandong Keyuan Pharmaceutical Co. Ltd. A capital reinvestment ratio. Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Capital Reinvestment Ratio of 1.89x as of December 2023, meaning it reinvests 2% of its operating cash flow (CN¥37.03 Million) in capital expenditures (CN¥70.15 Million). Check how aggressively does Shandong Keyuan Pharmaceutical Co. Ltd. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2023)
Capital reinvestment ratio of Shandong Keyuan Pharmaceutical Co. Ltd. A from 2021 to 2023. This chart tracks Shandong Keyuan Pharmaceutical Co. Ltd. A's Capital Reinvestment Ratio across 3 annual periods. Also explore net asset growth rate of Shandong Keyuan Pharmaceutical Co. Ltd. to track the company's year-over-year net asset growth rate.
Shandong Keyuan Pharmaceutical Co. Ltd. A Capital Reinvestment Ratio by Year (2021–2023)
Shandong Keyuan Pharmaceutical Co. Ltd. A capital reinvestment ratio by year from 2021 to 2023. For the full cash flow conversion analysis, see Shandong Keyuan Pharmaceutical Co. Ltd. cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.89x | CN¥37.03 Million | CN¥70.15 Million | ▲ +605.5% |
| 2022 | 0.27x | CN¥115.86 Million | CN¥31.11 Million | ▼ -30.8% |
| 2021 | 0.39x | CN¥52.02 Million | CN¥20.19 Million | — |